Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension

(2009) Sengwee Toh et al.   AMERICAN JOURNAL OF PSYCHIATRY

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes

(2009) K. L. Wisner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes

(2009) Najaaraq Lund et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy

(2009) Christina L. Wichman et al.   MAYO CLINIC PROCEEDINGS

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn

(2009) Susan E. Andrade et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

(2009) Markus Treichel et al.   World Journal of Pediatrics

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

(2008) Tim F. Oberlander et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study

(2008) Tim F. Oberlander et al.   BRITISH JOURNAL OF PSYCHIATRY

Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study

(2008) D. Li et al.   HUMAN REPRODUCTION

Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns

(2008) G. Dubnov-Raz et al.   PEDIATRICS

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

(2008) Bengt Källén et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY